Two well-characterized nongenomic actions of thyroid hormone in cultured brain tissues are: 1) regulation of type 2 iodothyronine 5deiodinase (D2) activity and 2) regulation of actin polymerization. In particular, the latter is likely to have profound effects on neuronal migration in the developing brain. In this study, we determined whether these nongenomic actions also occurred in vivo during brain development. Neonatal hypothyroidism was induced by propylthiouracil given to pregnant dams beginning on d17 of gestation and continued throughout the neonatal period. On postnatal d 14, rats were injected with either cold or [
T HYROID HORMONE has long been recognized as essential for regulation of the brain developmental program (1-7). The absence of thyroid hormone during the first 3 months of life in humans results in severe mental retardation and, in a rat model, irreversible morphological abnormalities in the brain (1) (2) (3) (4) (5) (6) (7) . Adequate thyroid hormone replacement in the infant with congenital hypothyroidism instituted soon after birth before these abnormalities develop successfully prevents these morphological abnormalities and allows brain development program to progress normally (8, 9) . Although the consequences of hypothyroidism on brain development are well recognized, the biochemical and molecular basis of the effects of this morphogenic hormone on neuronal integration remain elusive.
The major thyroid hormone produced by the thyroid gland is T 4 , which is deiodinated in peripheral tissues to the transcriptionally active iodothyronine, T 3 (10, 11) . T 4 is also deiodinated in peripheral tissues to the transcriptionally inert 3,3Ј,5Ј-triiodothyronine [reverse T 3 (rT 3 )], which is the predominant iodothyronine produced during fetal life (12) . The traditional model for thyroid hormone action has T 3 interacting with specific chromatin-bound ligand-activated transcription factors [thyroid hormone receptors (TRs)] (13, 14) . However, the identification of developmentally important, T 3 -responsive genes in the brain has been difficult at best and few, if any, obvious abnormalities in brain development have been observed in mutant mice lacking all known TRs (15, 16) , suggesting that T 3 -induced transcriptional regulation is not the sole contributor to the brain developmental program.
Nongenomic actions of the members of the steroid hormone super family are becoming increasingly important as mechanisms of hormone action (7, 17, 18) . In contrast to T 3 -dependent transcriptional actions that occur over hours to days, nongenomic actions of thyroid hormone typically occur in seconds to minutes and often involve T 4 as the ligand. Thus, for a nongenomic action to be relevant, the hormones must have rapid access to the tissue target of action. Nongenomic actions of thyroid hormone that have been described in brain cells include regulation of microfilament organization (19, 20) and regulation of type II iodothyronine 5Ј-deiodinase (D2) activity (21) (22) (23) (24) (25) (26) . In particular, thyroid hormone-dependent regulation of microfilament organization would likely have profound effects on the developing brain because the microfilaments are essential for the pathfinding and guidance of the migrating neurite (27) (28) (29) (30) (31) (32) .
We have described the nongenomic, thyroid hormonedependent regulation of the organization of the actin cytoskeleton both in cultured rat astrocytes (19, 33, 34) and in cultured rat granular neurons (20) . In astrocytes, approximately 90% of the cellular actin is polymerized and assembled into bundles of F-actin under euthyroid conditions. In the absence of thyroid hormone, the F-actin content falls by approximately 50% and the bundled microfilaments disappear; total cellular actin remains unchanged. T 4 and its metabolite, rT 3 , are equipotent in rapidly (ϳ10 min) promoting actin polymerization in astrocytes, returning the F-actin content to normal and restoring the stress fibers in the absence of transcription or translation. T 3 has no effect on actin po-lymerization at equimolar concentrations. Similarly, the Factin content in T 3 -treated and hormone-free granular neurons is decreased by up to 35% compared with the T 4 -or rT 3 -treated cells, with no change in total cellular actin (20) . Immunocytochemical analysis suggests that it is the F-actin that is found in the neuronal processes that is regulated by T 4 and rT 3 (20) . These in vitro studies correlate with a report that the F-actin content in the cerebellum of 14-d-old hypothyroid rats is significantly decreased and that T 4 replacement for 2 d restores the F-actin content to normal (35) .
In this study, we determined the time course of action of thyroid hormone on actin polymerization and D2 activity in vivo and correlated the alterations in actin polymerization and D2 activity with entry of iodothyronines into the developing rat brain. We show that T 4 , T 3 , and rT 3 all rapidly enter brain tissues after ip injection. Furthermore, we show that T 4 and rT 3 , but not T 3 , dynamically regulate actin polymerization and D2 activity in the developing brain.
Materials and Methods

Animals and reagents
Pregnant (16 -17 d gestation) Sprague Dawley rats were obtained from Charles-River Labs (Kingston, NY). The study was approved by the Animal Research Committee and complies with the institutional assurance certificate of the University of Massachusetts Medical School. Neonatal hypothyroidism was induced by adding propylthiouracil (PTU) (2 mg/liter) to the drinking water of pregnant dams beginning at d 17 of gestation and continuing throughout the neonatal period.
Iodothyronines were obtained from Henning GmBH (Berlin, Germany), iopanoic acid (IOP) was obtained from Sterling Winthrop Research Institute and BSA was purchased from Sigma (St. Louis, MO). Antirabbit IgG-horseradish peroxidase conjugate was purchased from Promega (Madison, WI), rabbit polyclonal anti-actin IgG was purchased from Biomedical Technologies (Stoughton, MA), and Hybond ECL nitrocellulose was obtained from Amersham (Arlington Heights, IL). The Lumiglo chemiluminescent was obtained from Kirkegaard & Perry Laboratories (Gaithersburg, MD). All other reagents were of the highest grade available. Where indicated, animals were also injected ip with IOP (50 g/10 g body weight), a potent inhibitor of 5Ј-deiodinase activity (11) , to block T 4 to T 3 conversion. Animals were exsanguinated via the abdominal aorta and perfused with 10 -20 ml iced 8 mm sodium phosphate (pH 7.4), 2.7 mm KCl, 137 mm NaCl, 1 mm IOP (PBS/IOP) at 0.5, 1, 3, and 6 h after injection. Blood samples obtained when the animals were killed were counted to determine the amount of [
Tissue analysis of iodothyronines
125 I]-labeled iodothyronine absorbed after injection. Cerebral cortex and cerebellum were harvested, washed in PBS/IOP, and frozen in liquid nitrogen and weighed. Iodothyronines were extracted and analyzed by HPLC according to established procedures (37, 38) . In brief, tissues were homogenized in 4 vol methanol/1 mm IOP and then extracted with 8 vol chloroform. The upper phase was collected and the bottom phase was extracted again with chloroform:methanol (2:1). The two upper phases were combined and extracted with 0.05% CaCl 2 . The aqueous phase was frozen, lyophilized, and resuspended in methanol. Samples were clarified by centrifugation, and the methanol was blown off under a nitrogen stream. Samples were then analyzed by HPLC and counted. The iodothyronine fractions were determined by parallel HPLC analysis of [
125 I]-labeled iodothyronine standards subjected to the same extraction procedures.
Tissue harvest and hormone assays
On postnatal d 14 (P14), PTU-treated rat pups were injected ip with T 4 , rT 3 , T 3 , or vehicle (1 m NaCl, 0.1% BSA, 100 l volume) and animals were killed at 1, 3, and 6 h after injection. Where indicated, animals were also injected ip with IOP (50 g/10 g body weight) to block T 4 to T 3 conversion. Control animals included postnatal d 14 euthyroid and PTU-treated animals and were killed at 0 and 6 h. In all experiments, animals were weighed, killed by decapitation and their blood collected for hormone assays. The cerebral cortex and cerebellum were rapidly isolated, washed in iced 8 mm sodium phosphate (pH 7.4), 2.7 mm KCl, 137 mm NaCl (PBS), frozen in liquid nitrogen, and kept at Ϫ70 C until use.
Serum TSH was measured in duplicate by RIA using materials obtained from the National Pituitary Agency, National Institutes of Health (Bethesda, MD). Serum T 4 , T 3 , and rT 3 were determined in duplicate by specific RIAs.
Actin analysis
Cerebellar samples were thawed and tissues were homogenized in 5 vol actin buffer [50 mm Tris (pH 6.8), 2 mm EDTA, 2 mm phenylmethylsulfonyl fluoride] and diluted to 1 mg protein/ml. Samples were solubilized by the addition of an equal volume of actin buffer containing 1% Triton X-100 (final Triton concentration 0.5%). The insoluble cytoskeletal pellet, containing F-actin, was separated from the soluble fraction, containing G-actin, by centrifugation in a microfuge at room temperature (39 -41) . The cytoskeletal pellet was solubilized in depolymerization buffer [1.5 m guanidine HCl, 1 m sodium acetate, 1 mm CaCl 2 , 1 mm ATP, 20 mm Tris HCl (pH 7.4)]. Both fractions were analyzed by immunoblot using a polyclonal rabbit antiactin IgG followed by an antirabbit IgG-horseradish peroxidase conjugate. Slot blots were developed with the Lumiglo chemiluminescent system and analyzed by scanning densitometry.
D2 analysis
Cerebral cortex samples were thawed and homogenized in 40 vol of 250 mm sucrose, 10 mm dithiothreitol (DTT), 1 mm EDTA, 20 mm HEPES (pH 7.0). D2 activity was determined in homogenates by the iodide release method at 2 nm rT 3 and 20 mm DTT in the presence of 1 mm PTU (22) . Units are expressed as fmol I Ϫ released/h.
Statistical methods
Results were analyzed by single-factor ANOVA.
Results
Analysis of the entry of iodothyronines into brain tissues
Before iodothyronines are able to enter the central nervous system (CNS), they must pass across the blood-brain barrier or through the choroid plexus-cerebrospinal fluid barrier (42) (43) (44) . Although many studies have shown that iodothyronines readily enter the brain (24, 38, (45) (46) (47) (48) (49) , there is still some debate as to possible differential entry of iodothyronines into the CNS. To study rapid actions of iodothyronines in the brain, we examined the time course of entry of iodothyronines into the cerebral cortex and the cerebellum after ip injection of [
125 I]-labeled iodothyronines into postnatal d 14 euthyroid rat pups.
All three iodothyronines were readily absorbed in to the bloodstream after ip injection (5-10% injected dose/ml at 1 h) and remained detectable throughout the experimental period (2-5% injected dose/ml at 6 h). In the cerebral cortex ( Fig. 1, top) , total [ 125 I] reached a peak at 1 h after the injection of T 4 and rT 3 , whereas a peak was not observed until 3 h after the injection of T 3 . At all time points, T 3 was 2-to 3-fold more abundant in the cortex than either T 4 or rT 3 ( Fig. 1, bottom) .
The tissue:plasma ratio at 3 h was similar with all three iodothyronines, indicating equal access to the cerebral cortex ( Table 1) . The steady decline of T 4 from 1-6 h in the cortex was blocked by the concurrent administration of IOP, a potent inhibitor of both type I and type II 5Ј-deiodinases (50) . Levels of rT 3 remained relatively stable over the 6-h period. In the cerebellum, peak tissue levels of total [
125 I] were achieved within 1 h after injection of rT 3 and within 3 h after the injection of T 4 and T 3 (Fig. 2, top) . Peak tissue levels of rT 3 were achieved in the cerebellum by 1 h and then fell to a plateau level from 3-6 h (Fig. 2, bottom) . T 3 steadily increased to peak tissue levels in the cerebellum by 3 h then plateaued, whereas T 4 reached peak tissue levels by 3 h, followed by a slow decrease by 6 h. As observed in the cortex, the concurrent administration of IOP blocked the decrease in T 4 tissue levels from 3-6 h; instead T 4 levels continued to steadily rise the cerebellum for up to 6 h after IOP administration. Similarly, the tissue:plama ratio at 3 h in the cerebellum was the same for all three iodothyronines and approximately 2-fold higher than in the cortex (Table 1 ). These studies show that all iodothyronines rapidly and equally enter developing brain tissues and remain in the CNS for at least 6 h after a bolus injection. The data represent the mean of results obtained in two separate experiments with six animals per experiment (n ϭ 12 total). 
Analysis of the rapid actions of thyroid hormone in the developing cerebral cortex and cerebellum
The above data clearly show that all iodothyronines rapidly enter the developing brain; thus, we were able to proceed and examine and compare the dynamic effects of iodothyronines on brain processes. Neonatal hypothyroidism was induced by adding PTU (2 mg/liter) to the drinking water of pregnant dams beginning at d 17 and continuing throughout the neonatal period. On postnatal d 14, rats were injected ip with T 4 (200 ng/10 g body weight), T 3 (40 ng/10 g body weight), rT 3 (200 ng/10 g body weight). Animals were killed and blood and tissues harvested 1-6 h after injection. Shown in Fig. 3 are the serum hormone concentrations in the experimental animals. PTU treatment resulted in undetectable T 4 and rT 3 concentrations and TSH concentrations 5-to 6-fold greater than that observed in the euthyroid animals. As observed previously (24, 51, 52), serum T 3 levels remained detectable in the PTU-treated animals at approximately 25% the level seen in the euthyroid animals. After the injection of T 4 , serum T 4 concentrations rose steadily to a maximum level at 3 h that was approximately 2-to 3-fold higher than in the euthyroid animals. Importantly, the only animals with detectable circulating T 4 were the euthyroid and T 4 -treated animals. Also after T 4 injection, serum T 3 concentrations steadily increased to euthyroid levels and rT 3 concentrations increased to approximately 8-fold greater than that observed in euthyroid animals over the 3-to 6-h time period, whereas TSH concentrations steadily fell to euthyroid levels by 6 h. After T 3 injection, serum T 3 concentrations increased to slightly above euthyroid levels (and higher than observed after T 4 injection) by 3 h then declined to euthyroid levels over the following 3 h. TSH concentrations also decreased by approximately 50% by 6 h after injection of T 3 , with no change in serum T 4 or rT 3 concentrations in the T 3 -treated animals. Similarly, rT 3 injection altered only serum rT 3 concentrations, increasing the levels to approximately 8-fold above that observed in euthyroid animals over the 3-to 6-h time period. As expected, there were no changes in serum hormone concentrations from the PTU-treated baseline in the animals injected with vehicle.
Dynamic regulation of D2 activity in the cerebral cortex
Regulation of D2 activity in the brain is a well-characterized nongenomic action of thyroid hormone and is a sensitive indicator of the cellular levels of thyroid hormone in the cerebral cortex (7, 22, 24, 26, 34, 40, 53) . D2 catalyzes T 4 to T 3 conversion within the brain and enzyme activity is inversely proportional to serum T 4 levels. In rat astrocytes, T 4 dynamically regulates D2 activity by activating actin-based endocytosis leading to the internalization of the enzyme and directing it to recycling pathways within the cell (26, 34, 40, 54, 55) . Using D2 as a marker of nongenomic thyroid hormone action, we examined the effects of individual iodothyronines on D2 activity in the developing rat cerebral cortex.
As shown previously (21, 22, 56) , D2 activity in the hypothyroid cerebral cortex is approximately 10-fold greater than that found in the euthyroid rat brain (Fig. 4) . The injection of vehicle alone or of T 3 at sufficient doses to produce euthyroid serum levels (Fig. 3 ) had no effect on D2 activity in the cerebral cortex over the 6 h period. In contrast, injection of both T 4 and rT 3 decreased D2 activity in the cerebral cortex by approximately 50% and 75%, respectively, within 30 min of injection (Fig. 4) . D2 activity decreased to levels observed in the euthyroid cortex within 3 h after either T 4 or rT 3 injection and remained stable from 3-6 h after injection. At all time points, D2 activity was significantly lower in either the T 4 -or rT 3 -treated rats compared with either the T 3 or vehicle-treated rats (P Ͻ 0.05). The effects of T 4 and rT 3 on D2 activity in the cerebral cortex are dose dependent, whereas T 3 continued to have no effect on D2 activity at equimolar concentrations (Table 1) .
Dynamic regulation of actin polymerization in the cerebellum
We next examined the effect of iodothyronines on the polymerization state of the microfilaments in the cerebellum. Previous studies showed that the cerebellum of hypothyroid postnatal d 14 rats had a lower amount of F-actin than the euthyroid rat cerebellum, with no change in total actin content (35) . We confirmed those findings and show that the F-actin content in the hypothyroid rat cerebellum is 30 -40% lower than in the euthyroid rat cerebellum at postnatal d 14 ( Fig. 5 ; Table 2 , P Ͻ 0.05 vs. euthyroid animal). In addition, the G-actin content in the cerebellum in the hypothyroid rat pups is greater than 2-fold higher than that found in the euthyroid rats (P Ͻ 0.001 vs. euthyroid animal). As shown previously (35) , total cerebellar actin content was unchanged in all conditions examined in this study (data not shown). Acute administration of either T 3 or vehicle did not affect either the G-actin or F-actin content in the hypothyroid rat cerebellum of the 6-h period. In contrast, T 4 and rT 3 both rapidly decreased G-actin content (P Ͻ 0.001 vs. PTU-treated animal) and increased the F-actin content in the PTU-treated rat cerebellum to that observed in the euthyroid cerebellum (P Ͻ 0.05 vs. PTU-treated animal) within 3 h (Fig. 5) . These effects persisted for at least 6 h. The T 4 -and rT 3 -dependent changes in G-and F-actin content are concentration-dependent, whereas T 3 has no effect even at high levels ( Table 2 ). These data indicate that T 4 and rT 3 , but not T 3 , dynamically regulate actin polymerization in the developing rat cerebellum.
Discussion
In the adult rat, local deiodination of T 4 serves as the major source of brain tissue T 3 and rT 3 (24, 50, 57) , potentially confounding the interpretation of T 4 -and rT 3 -specific actions in the brain. In particular, previous studies performed in adult rats suggested that access of rT 3 to brain tissues was markedly less than that of T 4 and T 3 (24, 45) , with local deiodination of T 4 serving as the primary, if not sole, source of rT 3 in the cerebral cortex (24) . In this paper, we show that serum T 4 , rT 3 , and T 3 all have equal and rapid access to cerebral cortical and cerebellar tissues in the developing rat. A likely explanation for this apparent discrepancy is the increased permeability to thyroid hormones of the blood: brain barrier in the developing brain (58 -60) . Because circulating T 4 , rT 3 , and T 3 absorbed after ip injection readily enter developing brain tissues, this study allows the direct evaluation of individual iodothyronines on the nongenomic regulation of D2 activity in the cerebral cortex and actin polymerization in the cerebellum of the developing rat.
As noted previously, regulation of D2 activity in the adult cerebral cortex is a well-characterized nongenomic action of thyroid hormone (21, 22, 53, 56) . This study shows that regulation of D2 by T 4 and rT 3 also occurs in the developing brain. As reported in the adult brain (21, 22, 53, 56) , D2 activity in the developing cerebral cortex is markedly increased in the absence of thyroid hormone. Acute administration of either T 4 or rT 3 caused cerebrocortical D2 levels in the hypothyroid rat pups to fall to euthyroid levels within 3 h, whereas injection of T 3 at concentrations sufficient to raise serum T 3 levels above the normal range failed to have any effect over that seen with vehicle alone (Fig. 4) . Importantly, injection of the hypothyroid rat pups with rT 3 increased serum levels of only rT 3 (Fig. 3) . Thus, because serum T 4 levels remained undetectable and serum T 3 levels remained low and unchanged, the fall in D2 activity in the hypothyroid rat cortex after injection of rT 3 is a direct effect of this inactive iodothyronine.
Underlying the regulation of D2 activity is the nongenomic regulation of actin polymerization by thyroid hormone in brain cells (19) . The expression of actin is developmentally 3 (200 ng/10 g BW), or vehicle, and animals were killed at 1, 3, and 6 h after injection. Where indicated, animals were also injected ip with IOP (50 g/10 g body weight). Control postnatal d 14 euthyroid and PTU-treated animals were killed at 0 and 6 h. Tissues were harvested and frozen in liquid nitrogen before use as discussed in Materials and Methods. Tissues were homogenized then solubilized with 0.5% Triton X-100. The soluble G-actin was separated from the insoluble F-actin fibers by centrifugation and the actin content in the soluble and insoluble fraction was analyzed by Western blot with an antiactin IgG as discussed in Materials and Methods. The G-actin content is expressed as a percent of the PTU-treated control animals, whereas the F-actin content is expressed as a percent of the euthyroid control animals. Results are presented as the mean of values obtained in triplicate animals in at least two experiments (n ϭ at least 6). regulated in the rat brain (35, 61, 62) . At birth, the F-actin content in the rat brain is low and, beginning at approximately postnatal d 5, steadily increases to adult levels over the next 2 wk (35, 61, 62) . Peak actin content is observed around postnatal d 8, after which levels fall to adult levels by the third week of life. Thyroid hormone has been reported to have no effect on the total actin content in the developing brain (35) , despite the observation that the peak actin mRNA content in the cerebellum is delayed by a few days in the hypothyroid rat (63) . However, the F-actin content in the developing hypothyroid rat cerebellum was reported to remain low until postnatal d 15-16, before steadily increasing to adult levels (35) . Treatment of the hypothyroid rat with T 4 normalized the F-actin content in the cerebellum within 4 d (35) .
In this study, we confirm the observation (35) that the F-actin content in the hypothyroid rat cerebellum at postnatal d 14 is significantly lower than in the euthyroid animal (Fig. 5) . Importantly, we show that the F-actin content in the hypothyroid rat cerebellum is rapidly (within 3 h) restored to normal by the administration of either T 4 or rT 3 . The increase in the F-actin content is associated with a reciprocal fall in the G-actin content, indicating changes in the polymerization state of the cellular actin as opposed to a change in the total cellular actin content. In contrast, T 3 had no effect on the F-actin content in the hypothyroid rat cerebellum (Fig.  5 ). Because T 3 readily enters cerebellar tissues (Fig. 2) , the inability for T 3 to modulate F-actin content in the cerebellum is not due to restricted access to the brain intracellular compartment. Similar to the actions of rT 3 on D2 activity, the increase in cerebellar F-actin content after injection of rT 3 is clearly a direct action of this iodothyronine. These in vivo data correlate well with previous in vitro observations on the regulation of actin polymerization by T 4 and rT 3 in cultured rat astrocytes (19, 40, 41) and rat neurons (20) . Similar to our observation in the cerebellum (Table 2) , T 4 and rT 3 are greater than 100-fold more potent than T 3 in promoting actin polymerization in cultured rat astrocytes and neurons.
Thyroid hormone-dependent regulation of actin polymerization is likely to play a major role in the brain developmental program. The microfilaments in both the neurons and the astrocytes play a key role during neuronal migration in the developing brain. The ability to regulate actin polymerization in the migrating neurite is essential to interpret extracellular guidance cues used by the migrating cell to follow specific pathways to their destination (27-30, 32, 64) . Chemical disruption of actin polymerization in cultured neurons markedly impairs neuronal growth cone motility and pathfinding ability in vitro (32, (65) (66) (67) . Furthermore, the T 4 -and rT 3 -dependent regulation of actin polymerization in neurons markedly blunts neuronal migration and neuronal process outgrowth in vitro (20) .
Regulation of actin polymerization in the supporting astrocytes is also essential for the organization of neuronal guidance molecules such as laminin on the astrocyte surface during brain development (68 -74) . Disruption of the microfilaments in cultured astrocytes also disrupts the formation of laminin arrays on the cell surface (75) . We have previously shown that the nongenomic thyroid hormone-dependent regulation of F-actin content in astrocytes modulates integrin:laminin interactions in astrocytes that, in turn, modulates the ability of astrocytes to fix and position laminin on the cell surface after secretion (34, 75) . This in vitro modulation of laminin patterning on the astrocyte surface also occurs in vivo because the appearance of laminin in the molecular layer in the developing hypothyroid rat cerebellum is both delayed and diminished compared with the euthyroid cerebellum (76) , without any change in laminin mRNA expression. Because the present study shows that thyroid hormone dynamically regulates actin polymerization in the developing brain, these data suggest that the thyroid hormone-dependent modulation of F-actin:integrin:laminin interactions occurs in vivo and is the likely etiology of the altered laminin appearance in the hypothyroid cerebellum.
This study also shows that rT 3 , an iodothyronine that has previously been considered an inactive metabolite of T 4 , indeed has direct regulatory actions on in vivo processes in the developing brain. Previous studies reported that a single injection of rT 3 decreased the pyknotic index in the hypothyroid neonatal cerebellum to euthyroid levels (77) . The ability of rT 3 to increase the F-actin content in the developing cerebellum provides a mechanism for this observation because pathfinding and migration would be restored to the migrating neurites in the presence of rT 3 . This would lead to more cells reaching their target destination and surviving rather than dying and becoming pyknotic. The regulation of F-actin content and D2 activity by rT 3 in the developing brain is the first demonstration of in vivo processes directly modulated by this iodothyronine. Our data suggest that the nongenomic regulation of actin polymerization plays a major role in neuronal migration during brain development. Indeed, although transcriptional gene regulation is the major mechanism of thyroid hormone action, alternative mechanism(s) of action need to be considered since the demonstration that mutant mice lacking all known TRs exhibit apparently normal brain development (15, 16) . Others have suggested a role for the unliganded receptor in thyroid hormone-mediated brain development because TRs bind to DNA in the unliganded state and in vitro studies have shown that the unliganded receptor can exert a negative effect on transcription (78) . Furthermore, inactivation of TR␣ prevented a hypothyroid phenotype in congenitally hypothyroid Pax8
(Ϫ/Ϫ) mice (79), although subsequent studies have suggested a more complex explanation for these observations (80) . However, when considering unliganded TRs as mediators of the abnormities observed in the hypothyroid brain, it is important to remember that the obligatorily unliganded TR␣2 is the most abundant TR isoform in the brain throughout development (81) . Furthermore, like the unliganded T 3 -binding TRs, TR␣2 has been reported to function as a transcriptional inhibitor in vitro (82, 83) . Importantly, there has been no direct in vivo demonstration of regulated gene repression by either the unliganded T 3 -binding TRs or by TR␣2; instead, all in vivo data have been inferential (i.e. hypothyroid mice exhibiting a more benign phenotype in the absence of expression, as noted above). Thus, it seems likely that non-TR-mediated processes are likely to contribute to the action of thyroid hormone on the developmental program of the brain.
In summary, we have shown that thyroid hormone dynamically regulates D2 activity and actin polymerization in the developing rat brain and that it likely does so via a nongenomic mechanism of action. The thyroid hormonedependent regulation of actin polymerization in the rat brain provides mechanism by which this morphogenic hormone can influence neuronal migration and development independent of the need for altered gene transcription. Furthermore, because rT 3 is equipotent to T 4 in the nongenomic regulation D2 activity and microfilament organization in both astrocytes and neurons (7, 19, 20, 33, 34) , and rT 3 is the most abundant iodothyronine during fetal life (12) , these data suggest a prominent role for this iodothyronine during brain development.
